Fort Washington Investment Advisors Inc. OH Has $27.92 Million Stake in Encompass Health Co. (NYSE:EHC)

Fort Washington Investment Advisors Inc. OH lifted its stake in shares of Encompass Health Co. (NYSE:EHC) by 0.3% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 302,272 shares of the company’s stock after acquiring an additional 830 shares during the period. Fort Washington Investment Advisors Inc. OH owned 0.30% of Encompass Health worth $27,915,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. TD Private Client Wealth LLC boosted its position in shares of Encompass Health by 2,870.0% during the 3rd quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock worth $709,000 after purchasing an additional 7,089 shares in the last quarter. Los Angeles Capital Management LLC grew its stake in Encompass Health by 532.4% in the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock valued at $4,860,000 after acquiring an additional 42,338 shares during the period. Pathstone Holdings LLC increased its holdings in shares of Encompass Health by 54.5% during the third quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock valued at $2,032,000 after acquiring an additional 7,412 shares in the last quarter. Deerfield Management Company L.P. Series C acquired a new position in shares of Encompass Health during the second quarter worth approximately $541,000. Finally, Meeder Asset Management Inc. lifted its holdings in shares of Encompass Health by 43.8% in the 3rd quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company’s stock worth $6,417,000 after purchasing an additional 20,242 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

EHC has been the subject of a number of recent research reports. Barclays boosted their price target on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Truist Financial reaffirmed a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Royal Bank of Canada boosted their price objective on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. UBS Group raised their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Finally, KeyCorp upped their price target on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Trading Down 1.4 %

Shares of Encompass Health stock opened at $94.47 on Thursday. The firm has a market cap of $9.52 billion, a PE ratio of 22.82, a P/E/G ratio of 1.13 and a beta of 0.89. Encompass Health Co. has a 1 year low of $69.95 and a 1 year high of $104.55. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a fifty day moving average price of $96.92 and a 200-day moving average price of $94.19.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter last year, the company posted $0.86 earnings per share. The firm’s quarterly revenue was up 11.9% compared to the same quarter last year. Equities research analysts anticipate that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.